WAIKOLOA, Hawaii — In this expert perspective from Hawaiian Eye 2026, John A. Hovanesian, MD, FACS, discusses a study assessing neurotrophic keratitis in cataract patients with dry eye.
Hovanesian, Healio | OSN Associate Medical Editor, said the study showed that 58% of these patients had stage 1 neurotrophic keratopathy based on Mackie criteria, resulting in corneal staining and reduced corneal sensation.
“Drugs like cenegermin (Oxervate) from Dompé are very valuable for this disease,” Hovanesian, of Harvard Eye Associates in Laguna Hills, California, told Healio. “They certainly may not be